Navigation Links
Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME)
Date:11/5/2009

y demonstrated using the Lumenis SRT laser. By irradiating the fundus with a train of 1.7 micro-second laser pulses it is possible to achieve high peak temperatures around the melanosomes, which leads to a destruction of the RPE, with only a low sub-lethal temperature increase in adjacent tissue structures. This process leads to the multiplication and migration of healthy RPE cells from the periphery which, in turn, help metabolize and improve the overall retina tissue health.

The Lumenis SRT laser was specifically designed to perform selective RPE targeting. This is accomplished by a green (frequency doubled Nd:YLF, 527nm) laser that emits 1.7 microsecond (¼s) pulses at a repetition rate of 100 Hertz (Hz). This low average power, delivered in a train of pulses, confines the laser treatment to the cells containing the target pigment or chromophores, in this case the melanin granules in the RPE cells, thereby achieving selective damage to these particular cells.

About Lumenis:
Lumenis, the world’s largest medical laser company, is a global developer, manufacturer and distributor of laser, light-based and radiofrequency devices for surgical, aesthetic and ophthalmic applications, with more than 800 employees worldwide. Lumenis has over 250 patents, over 75 FDA clearances, an installed base of over 80,000 systems and presence in over 100 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability. Consequently we are able to deliver premium value and service to our customers. Lumenis’ name is derived from Latin meaning “Light of Life”, highlighting the light which is the basis of our technologies used to enhance life. For more information about Lumenis and its products, please go to: www.lumenis.com.

For f
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
6. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
7. Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
8. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
9. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
10. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
11. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... The Radiology Business Management Association ... applied business information and intelligence, is proud to announce ... newsletter for its more than 2,000 members. , “RBMA ... news sources in that it is exclusively devoted to ... radiology. The newsletter is produced in cooperation with Thorn ...
(Date:4/27/2015)... Doping has been around sports for years ... continue to capture the public’s imagination, but so-called smart ... performance enhancement along with new ethical considerations. In an ... Anjan Chatterjee of Pennsylvania Hospital and the ... of these enhancements in sports. , Chatterjee studies the ...
(Date:4/27/2015)... 2015 Jvion, the Atlanta-based leader in ... and recognized as one of the top 40 fastest ... is presented by the Atlanta Business Chronicle, honors Atlanta’s ... status as an economic capital and employment hub. , ... spurred by the growing need to improve healthcare quality ...
(Date:4/26/2015)... Indianapolis, Indiana (PRWEB) April 26, 2015 ... network service provider announces that Brotherhood Mutual Insurance Company ... Daniel Armstrong, Manager of Network Infrastructure at Brotherhood Mutual ... value and the service reliability Brotherhood Mutual needed. ... route diversity, and IFN worked with us to ensure ...
(Date:4/26/2015)... This annual celebration is one of the ... include a spectacular collection of vendors offering distinctive gifts ... incense, chimes, vases, candleholders, fleece throws, trivets, jewelry and ... collection of vendors, guests will have the opportunity to ... Jimmie Jazz Band. , “We are ecstatic to ...
Breaking Medicine News(10 mins):Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 2Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 3Health News:Jvion Named to Top 40 Atlanta 2015 Pacesetters 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2
... Pays Cash When You Are Sick or Hurt?COLUMBUS, Ga., March 2 ... Aflac Duck as the mystery benefactor to policyholders who ... humorously shows how Aflac pays cash benefits when a medical ... night in a dark parlor. A group of friends is comforting ...
... March 2 DATATRAK International, Inc. (Nasdaq: ... global eClinical solutions for the clinical trials industry, today ... of Research and Development. In his role as DATATRAK,s ... to Raymond J. Merk, DATATRAK,s Chief Financial Officer and ...
... LCA-Vision Inc. (Nasdaq: LCAV ), a ... Plus (R) brand, today announced that members of its executive ... Institutional Investors Conference on Monday, March 9, 2009 at 8:40 ... The JW Marriott Grande Lakes Hotel in Orlando, Fla. ...
... study of children ages 8-11 years shows contact ... Athletic Competence, and Social Acceptance , JACKSONVILLE, ... benefits to children beyond simply correcting their nearsightedness ... physical appearance, acceptance among friends, and ability to ...
... Workplace Awards, Ten Honored for Best PracticesWASHINGTON, March ... can be felt across all industries, workplaces that ... times reap rewards for employer and employees alike, ... Psychologically Healthy Workplace Awards ceremony yesterday. Five organizations ...
... its 15,000th wish this summer , ... Pickering, ON, (PRWEB) March 2, ... three and 17 are diagnosed with a life-threatening illness. Every day more ... the efforts of The Children,s Wish Foundation of Canada and ...
Cached Medicine News:Health News:New Aflac Commercial Asks, 'Who Dun It?' 2Health News:New Aflac Commercial Asks, 'Who Dun It?' 3Health News:DATATRAK International, Inc. Announces the Return of Chris Wilke as Vice-President of R&D and the Issuance of a Patent 2Health News:DATATRAK International, Inc. Announces the Return of Chris Wilke as Vice-President of R&D and the Issuance of a Patent 3Health News:Children's Self-Perceptions Improve More With Contact Lenses vs. Glasses 2Health News:Children's Self-Perceptions Improve More With Contact Lenses vs. Glasses 3Health News:Children's Self-Perceptions Improve More With Contact Lenses vs. Glasses 4Health News:Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever 2Health News:Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever 3Health News:Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever 4Health News:Children's Wish, Canada's National Wish Granting Foundation Celebrates 25 Years 2Health News:Children's Wish, Canada's National Wish Granting Foundation Celebrates 25 Years 3
(Date:4/24/2015)... -- Hospira, Inc. (NYSE: HSP ), ... spoke about the importance of extrapolation in bringing biosimilars ... annual European Biosimilars Group conference in London ... publication of a pivotal white paper titled, "Why ... biosimilars." Speaking at the EGA conference, ...
(Date:4/23/2015)... , April 24, 2015  AbbVie (NYSE: ABBV ... Administration (FDA) has accepted its New Drug Application (NDA) ... two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), ... of adults with chronic genotype 4 (GT4) hepatitis C ... first all-oral, interferon-free therapy being evaluated by the FDA ...
(Date:4/23/2015)... 23, 2015 Once again, BeaconMedaes is meeting ... to patient safety. BeaconMedaes, priority is to ... disease. The next generation Zone Valve Box ... are now mounted in the assembly, allowing for ease ... ceiling tiles potentially releasing dust spores and other bacteria ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: